Comprehensive bioinformatics analysis of co-mutation of FLG2 and TP53 reveals prognostic effect and influences on the immune infiltration in ovarian serous cystadenocarcinoma
In the context of OV, the concurrent mutation of <i>FLG2</i> and <i>TP53</i> not only induces immune activation, but also helps identify a subset of patients with a more favorable prognosis.
Authors
- Jin Hao (ORCID: https://orcid.org/0000-0002-6685-2017)
- Meng Li (ORCID: https://orcid.org/0000-0003-0053-8620)
- Dongmei Han (ORCID: https://orcid.org/0000-0003-1557-0789)
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.21037/tcr-24-1596
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00